Stefan Korsatko
Graz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Effect of Liraglutide Treatment on Whole-body Glucose Fluxes in C-peptide-Positive Type 1 Diabetes During Hypoglycemia.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 09, 2021
Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2.
Journal: PloS one
Published: May 09, 2021
Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo-controlled, double-blind, crossover trial.
Journal: Diabetes, obesity & metabolism
Published: March 05, 2018
Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 17, 2017
A prolonged run-in period of standard subcutaneous microdialysis ameliorates quality of interstitial glucose signal in patients after major cardiac surgery.
Journal: Scientific reports
Published: July 04, 2017
The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes.
Journal: Drugs & aging
Published: June 20, 2015
Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial.
Journal: Diabetes, obesity & metabolism
Published: December 06, 2014
Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of action.
Journal: Journal of diabetes
Published: September 29, 2014
Ultra-long pharmacokinetic properties of insulin degludec are comparable in elderly subjects and younger adults with type 1 diabetes mellitus.
Journal: Drugs & aging
Published: November 23, 2013
PaQ®, a simple 3-day basal/bolus insulin delivery device, in people with type 2 diabetes.
Journal: Biomedizinische Technik. Biomedical engineering
Published: September 18, 2013
Certified dOFM sampling devices provide access to target tissue in pharmaceutical trials.
Journal: Biomedizinische Technik. Biomedical engineering
Published: September 18, 2013
Last Updated: 09/26/2026